A research group in Korea has discovered a novel natural antimicrobial peptide, "Hirunipin-2," from the salivary glands of ...

Constructive Bio in Cambridge now holds the exclusive licence to ‘tRNA Display’ technology from the MRC Laboratory of ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025.

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

DataM Intelligence | competitive Intelligence Achondroplasia drug market sees rising competition, with weekly and oral treatments targeting ...

Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee ...

Cancer remains one of the major global health threats. Tumors are not only influenced by gut microbiota but can also actively ...